Skip Navigation


NDT Advance Access originally published online on February 16, 2006
Nephrology Dialysis Transplantation 2006 21(4):839-843; doi:10.1093/ndt/gfl026
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/4/839    most recent
gfl026v2
gfl026v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Iseki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iseki, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Editorial Comment

Screening for renal disease—what can be learned from the Okinawa experience

Kunitoshi Iseki

Dialysis Unit, University Hospital of The Ryukyus, Japan

Correspondence and offprint requests to: Dr Kunitoshi Iseki, Dialysis Unit, University Hospital of The Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan. Email: chihokun@med.u-ryukyu.ac.jp

Keywords: chronic kidney disease; end-stage renal disease; hypertension; proteinuria; screening

The first 150 words of the full text of this article appear below.



   Introduction from Editorial office
 
Screening for renal disease—a lesson from East Asia
There is an ongoing discussion in Europe on whether screening for renal disease is sensible and cost-effective, be it universal screening or targeted screening in specific segments of the general population. Of course, screening for renal disease makes sense, not only with respect to prevention or retardation of end-stage renal disease, but—quantitatively even more so—with respect to prevention of cardiovascular complications.

Even when one considers the substantial demographic and biological differences between Okinawa islands and Western Europe, the unique data of the community-based screening programmes in Okinawa, covering more than 10% of the general population and continuing for more than two decades, are of substantial interest for Europeans, nephrologists as well as public health officials. They are a rich source of information on the benefits, but also the limitations, of screening programmes.

It is for this reason that the editors of Nephrology Dialysis Transplantation (NDT) have asked Dr Iseki to . . . [Full Text of this Article]



   Burden of end-stage renal disease in Okinawa
 


   Community-based screening programme in Okinawa, Japan
 


   ESRD patient registry in Okinawa
 


   Predictors of CKD and ESRD
 


   Limitations of our study
 


   Cost and benefits of screening
 


   Perspectives
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?